| scholarly article | Q13442814 |
| P50 | author | Albert Ferro | Q37843366 |
| P2093 | author name string | Rui Wang | |
| Yu Chen | |||
| Liping Xie | |||
| Xin Tang | |||
| Yong Ji | |||
| Yuqing Zhang | |||
| Zhengrong Huang | |||
| Yongfeng Shao | |||
| Philip K Moore | |||
| Guoliang Meng | |||
| Yujiao Xiao | |||
| Jinbiao Zhu | |||
| P2860 | cites work | Molecular imaging of the cardiac extracellular matrix | Q27687824 |
| H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure | Q33655952 | ||
| Hydrogen sulfide inhibits the renal fibrosis of obstructive nephropathy | Q33696105 | ||
| Hydrogen sulfide attenuates carbon tetrachloride-induced hepatotoxicity, liver cirrhosis and portal hypertension in rats | Q34055831 | ||
| Hydrogen sulphide suppresses human atrial fibroblast proliferation and transformation to myofibroblasts | Q34154740 | ||
| Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress | Q34580841 | ||
| Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts | Q34983872 | ||
| H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation | Q34994649 | ||
| Hydrogen sulfide alleviates myocardial collagen remodeling in association with inhibition of TGF-β/Smad signaling pathway in spontaneously hypertensive rats | Q35192817 | ||
| The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels. | Q36084474 | ||
| H₂S is an endothelium-derived hyperpolarizing factor. | Q51272873 | ||
| Inhibition of invasion and epithelial-mesenchymal transition of human breast cancer cells by hydrogen sulfide through decreased phospho-p38 expression. | Q53056135 | ||
| Diallyl sulfide induces cell cycle arrest and apoptosis in HeLa human cervical cancer cells through the p53, caspase- and mitochondria-dependent pathways. | Q53259981 | ||
| Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells. | Q53587374 | ||
| The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. | Q53956045 | ||
| Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats | Q68433121 | ||
| Characterisation of left ventricular collagen in the rat | Q72784519 | ||
| Chronic sodium hydrosulfide treatment decreases medial thickening of intramyocardial coronary arterioles, interstitial fibrosis, and ROS production in spontaneously hypertensive rats | Q80609679 | ||
| Protective effect of hydrogen sulfide on gentamicin-induced renal injury | Q87548519 | ||
| Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases | Q36342111 | ||
| Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner | Q36838022 | ||
| The pathogenesis of cardiac fibrosis. | Q37161329 | ||
| Hydrogen sulfide mediates cardioprotection through Nrf2 signaling | Q37328256 | ||
| Aging, exercise, and extracellular matrix in the heart | Q37332371 | ||
| Tempol attenuates renal fibrosis in mice with unilateral ureteral obstruction: the role of PI3K-Akt-FoxO3a signaling | Q37583050 | ||
| The role of alpha-smooth muscle actin in myogenic differentiation of human glandular stem cells and their potential for smooth muscle cell replacement therapies | Q37724366 | ||
| Signaling pathways for the vascular effects of hydrogen sulfide | Q37837422 | ||
| Biomarkers of myocardial fibrosis | Q37855500 | ||
| Physiological implications of hydrogen sulfide: a whiff exploration that blossomed | Q38005671 | ||
| Stem cell transplantation as a therapy for cardiac fibrosis. | Q38046544 | ||
| Myofibroblast-mediated mechanisms of pathological remodelling of the heart | Q38064729 | ||
| Hydrogen sulfide and the pathogenesis of atherosclerosis | Q38098634 | ||
| The therapeutic potential of miRNAs in cardiac fibrosis: where do we stand? | Q38118947 | ||
| Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease. | Q38134341 | ||
| Investigational drugs targeting cardiac fibrosis | Q38161896 | ||
| Dynamic changes in myocardial matrix and relevance to disease: translational perspectives | Q38191847 | ||
| Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia. | Q38236845 | ||
| Decreased expression of p38 MAPK mediates protective effects of hydrogen sulfide on hepatic fibrosis | Q39173217 | ||
| Determination of hydroxyproline | Q39967323 | ||
| Hydrogen sulfide attenuates cardiac hypertrophy and fibrosis induced by abdominal aortic coarctation in rats | Q41349390 | ||
| Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model | Q41856390 | ||
| Diallylsulfide attenuates excessive collagen production and apoptosis in a rat model of bleomycin induced pulmonary fibrosis through the involvement of protease activated receptor-2. | Q42711443 | ||
| Inhibition of NADPH oxidase 4-related signaling by sodium hydrosulfide attenuates myocardial fibrotic response. | Q44773974 | ||
| Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion | Q45840647 | ||
| Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. | Q45947130 | ||
| Synergistic attenuation of myocardial fibrosis in spontaneously hypertensive rats by joint treatment with benazepril and candesartan. | Q45986994 | ||
| Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice | Q46260974 | ||
| Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide | Q46621665 | ||
| Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro. | Q46658810 | ||
| Animal models of cardiac fibrosis | Q46676482 | ||
| Diallyl trisufide (DATS) suppresses high glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFκB signaling via attenuating ROS generation | Q46976904 | ||
| Posterior diaphragm agenesis: when liver simulates lungs. | Q47823576 | ||
| Exogenous hydrogen sulfide protects H9c2 cardiac cells against high glucose-induced injury by inhibiting the activities of the p38 MAPK and ERK1/2 pathways. | Q47864828 | ||
| Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction | Q48024039 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 691070 | |
| P577 | publication date | 2015-05-11 | |
| P1433 | published in | Oxidative medicine and cellular longevity | Q26840015 |
| P1476 | title | Hydrogen Sulfide Donor GYY4137 Protects against Myocardial Fibrosis | |
| P478 | volume | 2015 |
| Q62381232 | A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer? |
| Q60952208 | Exogenous Hydrogen Sulfide Supplement Attenuates Isoproterenol-Induced Myocardial Hypertrophy in a Sirtuin 3-Dependent Manner |
| Q46581242 | Exogenous hydrogen sulphide ameliorates diabetic cardiomyopathy in rats by reversing disordered calcium-handling system in sarcoplasmic reticulum |
| Q94562632 | GYY4137 a H2S donor, attenuates ipsilateral epididymis injury in experimentally varicocele-induced rats via activation of the PI3K/Akt pathway |
| Q57300054 | Hydrogen Sulfide (HS)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases |
| Q64991647 | Hydrogen Sulfide Ameliorates Homocysteine-Induced Cardiac Remodeling and Dysfunction. |
| Q89736835 | Hydrogen Sulfide as a Potential Alternative for the Treatment of Myocardial Fibrosis |
| Q39906675 | Hydrogen sulfide depletion contributes to microvascular remodeling in obesity |
| Q47914860 | International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors |
| Q64234079 | Modulation of miR-10a-mediated TGF-β1/Smads signaling affects atrial fibrillation-induced cardiac fibrosis and cardiac fibroblast proliferation |
| Q39240558 | Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system |
| Q36085536 | Oxymatrine inhibits aldosterone-induced rat cardiac fibroblast proliferation and differentiation by attenuating smad-2,-3 and-4 expression: an in vitro study |
| Q61818125 | Protective Smell of Hydrogen Sulfide and Polysulfide in Cisplatin-Induced Nephrotoxicity |
| Q33618317 | Protective effect of hydrogen sulphide against myocardial hypertrophy in mice |
| Q38692090 | Protein S-sulfhydration by hydrogen sulfide in cardiovascular system |
| Q28066719 | The Role of Hydrogen Sulfide in Renal System |
| Q47284733 | Transient receptor potential vanilloid-3 (TRPV3) activation plays a central role in cardiac fibrosis induced by pressure overload in rats via TGF-β1 pathway |
Search more.